Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02449213 · ClinicalTrials.gov registry record
A Biobehavioral Model of Diabetes Risk in Chinese Immigrants
A clinical trial, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- 650
- Enrollment target
NCT02449213: Completed study, sponsored by Fox Chase Cancer Center.
NCT02449213 is a clinical trial that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 650 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02449213 has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- 650 participants
- Enrollment target
Study Summary
This prospective, longitudinal study of Chinese American immigrants will examine whether psychosocial factors (e.g., acculturative stress, social isolation, discrimination) are associated with markers of type 2 diabetes risk over time, and whether such associations are mediated by inflammatory pathways.
Primary Outcome
Insulin resistance will be estimated according to the homeostasis model assessment (HOMA) as HOMA = (fasting insulin x fasting glucose) / 22.5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2016-03-11 |
| Est. Completion | 2021-05-05 |
What the finished NCT02449213 record still lists
NCT02449213 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02449213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02449213 about?
NCT02449213 is a clinical study titled "A Biobehavioral Model of Diabetes Risk in Chinese Immigrants". This prospective, longitudinal study of Chinese American immigrants will examine whether psychosocial factors (e.g., acculturative stress, social isolation, discrimination) are associated with markers of type 2 diabetes risk over time, and whether such associations are mediated by inflammatory pathw...
What is the current status of trial NCT02449213?
This trial is currently completed. The enrollment target is 650 participants. The study started on 2016-03-11. Estimated completion is 2021-05-05.
Who is sponsoring clinical trial NCT02449213?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI